Autonomic nervous system control of the cardiovascular and respiratory systems in asthma.
暂无分享,去创建一个
A. L. Short | M. Lewis | M J Lewis | A L Short | K E Lewis | K. Lewis | M. Lewis | Keir Lewis
[1] A. Tattersfield,et al. The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects. , 1999, The European respiratory journal.
[2] E. R. Mcfadden,et al. Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis. , 1986, The Journal of clinical investigation.
[3] R. Cohen,et al. Hemodynamic regulation: investigation by spectral analysis. , 1985, The American journal of physiology.
[4] K. Belmonte. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[5] J. V. van Vlymen,et al. The Duration of Impairment of Autonomic Control After Anticholinergic Drug Administration in Humans , 1997, Anesthesia and analgesia.
[6] W. C. Randall,et al. SA nodal parasympathectomy delineates autonomic control of heart rate power spectrum. , 1991, The American journal of physiology.
[7] B. Canning,et al. Regulation of baseline cholinergic tone in guinea‐pig airway smooth muscle , 1999, The Journal of physiology.
[8] H. Huikuri,et al. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: effects of various respiratory patterns. , 2001, Clinical physiology.
[9] R. Pierson,et al. Mechanism of bronchoconstriction due to beta adrenergic blockade. Studies with practolol, propranolol, and atropine. , 1971, The Journal of allergy and clinical immunology.
[10] K. Hirata,et al. Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma. , 2000, The Journal of allergy and clinical immunology.
[11] A. Porta,et al. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. , 1994, Circulation.
[12] J. Nadel. Autonomic control of airway smooth muscle and airway secretions. , 1977, The American review of respiratory disease.
[13] W. Busse. Pathogenesis and pathophysiology of nocturnal asthma. , 1988, The American journal of medicine.
[14] J. Kline,et al. Vitamin A deficiency promotes bronchial hyperreactivity in rats by altering muscarinic M(2) receptor function. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[15] M. Turiel,et al. Power Spectral Analysis of Heart Rate and Arterial Pressure Variabilities as a Marker of Sympatho‐Vagal Interaction in Man and Conscious Dog , 1986, Circulation research.
[16] A. Koziell,et al. Does the sympathetic nervous system influence sinus arrhythmia in man? Evidence from combined autonomic blockade. , 1984, The Journal of physiology.
[17] J. Schwartz,et al. β‐Adrenoceptors of the human myocardium: determination of β1 and β2 subtypes by radioligand binding , 1983 .
[18] F. Crea,et al. Effects of beta2-adrenoceptor stimulation on exercise-induced myocardial ischemia , 1991 .
[19] P. Howarth,et al. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. , 2001, Thorax.
[20] J. Crane,et al. The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals , 2004, European Journal of Clinical Pharmacology.
[21] A. Pappano,et al. The parasympathetic neuroeffector junction of the heart. , 1985, Pharmacological reviews.
[22] M. Koulu,et al. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. , 1987, British journal of clinical pharmacology.
[23] H. Dean,et al. Parasympathetic nervous system in nocturnal asthma , 1988, British medical journal.
[24] C. Dollery,et al. Increased pulmonary α-adrenergic and reduced β-adrenergic receptors in experimental asthma , 1980, Nature.
[25] E. R. Mcfadden,et al. Exhaled nitric oxide and thermally induced asthma. , 2001, American journal of respiratory and critical care medicine.
[26] M. Kaliner. The cholinergic nervous system and immediate hypersensitivity. 1. Eccrine sweat responses in allergic patients. , 1976, The Journal of allergy and clinical immunology.
[27] N. Gross,et al. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent. , 1987, The American review of respiratory disease.
[28] T. Kuusela,et al. The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure. , 1998, British journal of clinical pharmacology.
[29] B. Silke,et al. Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods. , 1999, British journal of clinical pharmacology.
[30] P. Barnes,et al. Autonomic regulation of the airways. , 1984, Annual review of medicine.
[31] P. O'Byrne,et al. Methacholine airway responsiveness decreases during exercise in asthmatic subjects. , 1990, The American review of respiratory disease.
[32] A. Fryer,et al. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.
[33] D. Jacoby. Virus-induced asthma attacks. , 2002, JAMA.
[34] P. Howarth,et al. Induction of nitric oxide synthase in asthma , 1993, The Lancet.
[35] A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity. , 1987, The Journal of allergy and clinical immunology.
[36] N. Pearce,et al. PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY , 1989, The Lancet.
[37] G. Gleich,et al. Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[38] A. Wellstein,et al. Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.
[39] P. Macklem,et al. Distribution of regional ventilation measured by breath sounds. , 1978, The American review of respiratory disease.
[40] R. Kleiger. Heart Rate Variability and Mortality and Sudden Death Post Infarction , 1995, Journal of cardiovascular electrophysiology.
[41] F. Leenen,et al. Hemodynamic effects of an inhaled beta‐2 agonist , 1984, Clinical pharmacology and therapeutics.
[42] P. Sterk,et al. Cardiovascular side e V ects of inhaled salbutamol in hypoxic asthmatic patients , 2001 .
[43] R. Creasy,et al. Cardiovascular complications associated with terbutaline treatment for preterm labor. , 1981, American journal of obstetrics and gynecology.
[44] S. Pearson,et al. The effect of the circadian rhythm of vagal activity on bronchomotor tone in asthma. , 1989, British journal of clinical pharmacology.
[45] Ultan McDermott,et al. Time and frequency domain assessment of heart rate variability: A theoretical and clinical appreciation , 1993, Clinical Autonomic Research.
[46] P. Barnes. Neural mechanisms in asthma. , 1992, British medical bulletin.
[47] J. Shelhamer,et al. Autonomic nervous system abnormalities and allergy. , 1982, Annals of internal medicine.
[48] S. Jennings,et al. Effect of adrenergic and vagal blockade on the normal human airway response to exercise. , 1983, Clinical science.
[49] S. Scalvini,et al. Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[50] M. Silverman,et al. Circulating catecholamines in exercise and hyperventilation induced asthma. , 1981, Thorax.
[51] D. Lipson,et al. Opposing central and peripheral effects of atropine on parasympathetic cardiac control. , 1977, The American journal of physiology.
[52] Mary Jane Thomassen,et al. Regulation of No Synthesis Transcriptional and Post-translational Oxide (no) in Asthma: Evidence for Molecular Mechanisms of Increased Nitric , 2013 .
[53] Casale Tb. Neuromechanisms of asthma. , 1987, Annals of allergy.
[54] J. V. van Noord,et al. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease , 2000 .
[55] R. Cohen,et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. , 1981, Science.
[56] P. Barnes,et al. Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways. , 1991, European journal of pharmacology.
[57] T. Kuusela,et al. Cardiovascular autonomic regulation in asthmatic children evidenced by spectral analysis of heart rate and blood pressure variability. , 1996, Scandinavian journal of clinical and laboratory investigation.
[58] A Malliani,et al. Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. , 1994, The American journal of cardiology.
[59] Arthur S Slutsky,et al. Assessment of airway tone in asthma. Comparison between double lung transplant patients and healthy subjects. , 1993, The American review of respiratory disease.
[60] M. Kollai,et al. Relation between baroreflex sensitivity and cardiac vagal tone in humans. , 1994, The American journal of physiology.
[61] L. Fabbri,et al. Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. , 1999, American journal of respiratory and critical care medicine.
[62] P. Bjerregaard,et al. Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. , 1993, The American journal of cardiology.
[63] C. Sartori,et al. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. , 1997, Circulation.
[64] P. Devillier,et al. Inhibition by SR 59119A of isoprenaline-, forskolin- and VIP-induced relaxation of human isolated bronchi. , 2000, Pulmonary pharmacology & therapeutics.
[65] Nieminen,et al. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart‐rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease , 1998, Journal of internal medicine.
[66] M. Lesh,et al. Autonomic nervous system and sudden cardiac death. , 1996, Journal of the American College of Cardiology.
[67] J M Kallenbach,et al. Reflex heart rate control in asthma. Evidence of parasympathetic overactivity. , 1985, Chest.
[68] L. Cesar. Freqüência cardíaca e risco cardiovascular , 2007 .
[69] S. Julius,et al. Heart rate and the cardiovascular risk , 1997, Journal of hypertension.
[70] M. Palmisano,et al. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder Inhalation via aerolizerTM , 1999, European Journal of Clinical Pharmacology.
[71] K. Austen,et al. IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNG , 1971, The Journal of experimental medicine.
[72] E. Salpeter,et al. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. , 2004, Chest.
[73] B. Lipworth,et al. Evaluation of partial β‐adrenoceptor agonist activity , 1997 .
[74] Blunted sympathoadrenal response to exercise in asthmatic subjects. , 1982, British journal of diseases of the chest.
[75] K. M. Spyer. Central nervous integration of cardiovascular control. , 1982, The Journal of experimental biology.
[76] D. Adam,et al. Assessment of autonomic function in humans by heart rate spectral analysis. , 1985, The American journal of physiology.
[77] B. Canning,et al. Neural regulation of airway smooth muscle tone. , 2001, Respiration physiology.
[78] H. Scheinin,et al. Spectral analysis of heart rate variability as a quantitative measure of parasympatholytic effect--integrated pharmacokinetics and pharmacodynamics of three anticholinergic drugs. , 1999, Therapeutic drug monitoring.
[79] T. Kuusela,et al. Nonlinear methods of biosignal analysis in assessing terbutaline-induced heart rate and blood pressure changes. , 2002, American journal of physiology. Heart and circulatory physiology.
[80] A. Malliani,et al. Cardiovascular Neural Regulation Explored in the Frequency Domain , 1991, Circulation.
[81] M. Seishima,et al. Autonomic regulation after exercise evidenced by spectral analysis of heart rate variability in asthmatic children. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[82] J. Crane,et al. The extrapulmonary effects of increasing doses of formoterol in patients with asthma , 1998, European Journal of Clinical Pharmacology.
[83] A. Mistretta,et al. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. , 1992, The European respiratory journal.
[84] A Malliani,et al. Circadian variation of spectral indices of heart rate variability after myocardial infarction. , 1992, American heart journal.
[85] J. Lundberg,et al. Pulmonary effects of endogenous and exogenous nitric oxide in the pig: relation to cigarette smoke inhalation , 1993, British journal of pharmacology.
[86] A. Malliani,et al. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .
[87] A. Tattersfield,et al. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. , 1997, Thorax.
[88] K. Chung,et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma , 2000, Thorax.
[89] Y. Jammes,et al. Assessment of the pulmonary origin of bronchoconstrictor vagal tone , 1979, The Journal of physiology.
[90] P. Manglick,et al. Systemic absorption of salbutamol following nebulizer delivery in acute asthma , 1993, Acta paediatrica.
[91] K. Sommers,et al. Possible mechanisms of anti-cholinergic drug-induced bradycardia , 2004, European Journal of Clinical Pharmacology.
[92] A. Teisman,et al. Dysfunctional muscarinic M2 autoreceptors in vagally induced bronchoconstriction of conscious guinea pigs after the early allergic reaction. , 1996, European journal of pharmacology.
[93] T. Kuusela,et al. Altered cardiovascular autonomic regulation after salmeterol treatment in asthmatic children. , 1998, Clinical physiology.
[94] J. Nadel,et al. Reflex effects of upper airway irritation on total lung resistance and blood pressure. , 1962, Journal of applied physiology.
[95] P. Corris,et al. Nebulised salbutamol and angina. , 1982, British medical journal.
[96] A. Tattersfield,et al. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects , 2000, Thorax.
[97] D. Eckberg,et al. Important influence of respiration on human R-R interval power spectra is largely ignored. , 1993, Journal of applied physiology.
[98] I. Horváth,et al. Relation between bronchial and cardiac vagal tone in healthy humans. , 1995, Chest.
[99] D. Flenley,et al. Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. , 1976, British medical journal.
[100] Y. Donchin,et al. Spectral analysis of fetal heart rate in sheep: the occurrence of respiratory sinus arrhythmia. , 1984, American journal of obstetrics and gynecology.
[101] P. Lehrer,et al. Effects of aerosol ipratropium bromide on cardiac vagal tone. , 1994, Chest.
[102] B. Lipworth,et al. Cardiopulmonary interactions of salbutamol and hypoxaemia in healthy young volunteers. , 1995, British journal of clinical pharmacology.
[103] R. Tarazi,et al. Assessment of parasympathetic control of heart rate by a noninvasive method. , 1984, The American journal of physiology.
[104] M. Ennis,et al. Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects. , 1998, Thorax.
[105] Webster Dc,et al. Drug therapy: Bronchodilator therapy (first of two parts). , 1977 .
[106] J. Widdicombe,et al. REFLEX CONTROL OF AIRWAY SIZE * , 1963, Annals of the New York Academy of Sciences.
[107] J. Bradshaw,et al. Medical audit , 1975, The Lancet.
[108] S. Macleod,et al. Anti-Allergy and Anti-Asthma Drugs , 1989, Clinical pharmacokinetics.
[109] G. Anderson,et al. Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation. , 2000, American journal of respiratory and critical care medicine.
[110] K. Ashutosh,et al. Nitric oxide and asthma: a review. , 2000, Current opinion in pulmonary medicine.
[111] P. Barnes,et al. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. , 1985, The American review of respiratory disease.
[112] O. Brodde. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. , 1991, Pharmacological reviews.
[113] J. Palmer,et al. Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. , 1977, British medical journal.
[114] K. Antila,et al. Effects of glycopyrrolate and atropine on heart rate variability , 1991, Acta anaesthesiologica Scandinavica.
[115] S. Jain,et al. Clinical dysautonomia in patients with bronchial asthma. Study with seven autonomic function tests. , 1990, Chest.
[116] A. Malliani,et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. , 1990, Circulation.
[117] M. Hilton,et al. Endogenous circadian control of the human autonomic nervous system , 2000, Computers in Cardiology 2000. Vol.27 (Cat. 00CH37163).
[118] A. Seidler,et al. Spectral analysis of heart rate variability in bronchial asthma , 1992, Clinical Autonomic Research.
[119] Beat-to-beat variation of the heart rate in children with allergic asthma. , 1985, The Journal of asthma : official journal of the Association for the Care of Asthma.
[120] H. Ross,et al. Nitric oxide and cardiac autonomic control in humans. , 2000, Hypertension.
[121] I. Adcock,et al. Transcription factors and asthma. , 1998, The European respiratory journal.
[122] B. Eryonucu,et al. Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients. , 2001, The European respiratory journal.
[123] A. Wellstein,et al. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots. , 1988, The Journal of pharmacology and experimental therapeutics.
[124] D. Lambert,et al. Muscarinic receptor subtypes: do they have a place in clinical anaesthesia? , 1995, British journal of anaesthesia.